CN103239707A - Eye drop for treating myopia - Google Patents

Eye drop for treating myopia Download PDF

Info

Publication number
CN103239707A
CN103239707A CN2013101918853A CN201310191885A CN103239707A CN 103239707 A CN103239707 A CN 103239707A CN 2013101918853 A CN2013101918853 A CN 2013101918853A CN 201310191885 A CN201310191885 A CN 201310191885A CN 103239707 A CN103239707 A CN 103239707A
Authority
CN
China
Prior art keywords
parts
eye drop
myopia
silver ion
flos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013101918853A
Other languages
Chinese (zh)
Inventor
袁伯才
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU ZISHI CHEMICAL TECHNOLOGY Co Ltd
Original Assignee
JIANGSU ZISHI CHEMICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU ZISHI CHEMICAL TECHNOLOGY Co Ltd filed Critical JIANGSU ZISHI CHEMICAL TECHNOLOGY Co Ltd
Priority to CN2013101918853A priority Critical patent/CN103239707A/en
Publication of CN103239707A publication Critical patent/CN103239707A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses an eye drop for treating myopia. The eye drop comprises the following components in parts by weight: 4-7 parts of flos chrysanthemi indici, 3.5-3.9 parts of honeysuckle, 9-10 parts of cuscuta chinensis, 3-3.9 parts of oleum menthae, 6-9.8 parts of silver ion solution, and 4-8.9 parts of mulberry silk fiber. The eye drop can alleviate asthenopia.

Description

The eye drop for the treatment of myopia
Technical field
The present invention relates to a kind of eye drop, be specifically related to a kind of eye drop for the treatment of myopia.
Background technology
Existing eye drop is remitting vision fatigue, and does not have therapeuticing and health effect.
Summary of the invention
Goal of the invention: the present invention provides a kind of eye drop for the treatment of myopia in order to solve the deficiencies in the prior art.
Technical scheme: a kind of eye drop for the treatment of myopia, formed by following each compositions in weight portion: Flos Chrysanthemi Indici 4-7 part, Flos Lonicerae 3.5-3.9 part, Semen Cuscutae 9-10 part, Oleum menthae 3-3.9 part, silver ion solution 6-9.8 part, mulberry silk fiber 4-8.9 part.
As preferably, described eye drop is made up of following each compositions in weight portion: 5 parts of Flos Chrysanthemi Indicis, 3.7 parts of Flos Loniceraes, 9.5 parts of Semen Cuscutae, 3.5 parts of Oleum menthae, 7.3 parts of silver ion solutions, 6 parts of mulberry silk fibers.
Beneficial effect: the present invention compares with existing technology, can alleviate myopia.
The specific embodiment
The present invention will be described in detail below in conjunction with specific embodiment.
Specific embodiment:
Embodiment 1:
A kind of eye drop for the treatment of myopia is made up of following each compositions in weight portion: 4 parts of Flos Chrysanthemi Indicis, Flos Lonicerae 3.5-part, 9 parts of Semen Cuscutae, 3 parts of Oleum menthae, 6 parts of silver ion solutions, 4 parts of mulberry silk fibers.
Embodiment 2:
A kind of eye drop for the treatment of myopia is made up of following each compositions in weight portion: 5 parts of Flos Chrysanthemi Indicis, 3.7 parts of Flos Loniceraes, 9.5 parts of Semen Cuscutae, 3.5 parts of Oleum menthae, 7.3 parts of silver ion solutions, 6 parts of mulberry silk fibers.
Embodiment 3:
A kind of eye drop for the treatment of myopia is made up of following each compositions in weight portion: 7 parts of Flos Chrysanthemi Indicis, 3.9 parts of Flos Loniceraes, 10 parts of Semen Cuscutae, 3.9 parts of Oleum menthae, 9.8 parts of silver ion solutions, 8.9 parts of mulberry silk fibers.

Claims (2)

1. treat near-sighted eye drop for one kind, it is characterized in that: described eye drop is made up of following each compositions in weight portion: Flos Chrysanthemi Indici 4-7 part, Flos Lonicerae 3.5-3.9 part, Semen Cuscutae 9-10 part, Oleum menthae 3-3.9 part, silver ion solution 6-9.8 part, mulberry silk fiber 4-8.9 part.
2. the eye drop for the treatment of myopia as claimed in claim 1, it is characterized in that: described eye drop is made up of following each compositions in weight portion: 5 parts of Flos Chrysanthemi Indicis, 3.7 parts of Flos Loniceraes, 9.5 parts of Semen Cuscutae, 3.5 parts of Oleum menthae, 7.3 parts of silver ion solutions, 6 parts of mulberry silk fibers.
CN2013101918853A 2013-05-22 2013-05-22 Eye drop for treating myopia Pending CN103239707A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013101918853A CN103239707A (en) 2013-05-22 2013-05-22 Eye drop for treating myopia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013101918853A CN103239707A (en) 2013-05-22 2013-05-22 Eye drop for treating myopia

Publications (1)

Publication Number Publication Date
CN103239707A true CN103239707A (en) 2013-08-14

Family

ID=48919810

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013101918853A Pending CN103239707A (en) 2013-05-22 2013-05-22 Eye drop for treating myopia

Country Status (1)

Country Link
CN (1) CN103239707A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394355B2 (en) 2014-08-20 2016-07-19 Silk Technologies, Ltd. Fibroin-derived protein composition
CN111097036A (en) * 2019-05-05 2020-05-05 刘祝成 Eye care compositions, products and methods of use thereof
US10953132B2 (en) 2016-04-08 2021-03-23 Cornell University Method to enhance wound healing using silk-derived protein
US11242367B2 (en) 2016-08-12 2022-02-08 Silk Technologies, Ltd. Silk-derived protein for treating inflammation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1650998A (en) * 2002-06-03 2005-08-10 宋志民 Preparation method of Chinese medicinal eye drops for treating myopia
CN101642505A (en) * 2008-08-04 2010-02-10 刘燕超 Eye drop for treating myopic eyes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1650998A (en) * 2002-06-03 2005-08-10 宋志民 Preparation method of Chinese medicinal eye drops for treating myopia
CN101642505A (en) * 2008-08-04 2010-02-10 刘燕超 Eye drop for treating myopic eyes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
冯贵林等: ""近视眼的中药治疗"", 《中华实用医药杂志》, vol. 5, no. 16, 31 August 2005 (2005-08-31) *
戎曙欣等: ""李清文教授从肝论治眼病的经验"", 《河北中医》, vol. 29, no. 1, 31 January 2007 (2007-01-31) *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394355B2 (en) 2014-08-20 2016-07-19 Silk Technologies, Ltd. Fibroin-derived protein composition
US9907836B2 (en) 2014-08-20 2018-03-06 Silk Technologies, Ltd. Fibroin-derived protein composition
US10471128B2 (en) 2014-08-20 2019-11-12 Silk Technologies, Ltd. Fibroin-derive protein composition
US11045524B2 (en) 2014-08-20 2021-06-29 Silk Technologies, Ltd. Fibroin-derived protein composition
US11890328B2 (en) 2014-08-20 2024-02-06 Silk Technologies, Ltd. Fibroin-derived protein composition
US10953132B2 (en) 2016-04-08 2021-03-23 Cornell University Method to enhance wound healing using silk-derived protein
US11242367B2 (en) 2016-08-12 2022-02-08 Silk Technologies, Ltd. Silk-derived protein for treating inflammation
CN111097036A (en) * 2019-05-05 2020-05-05 刘祝成 Eye care compositions, products and methods of use thereof

Similar Documents

Publication Publication Date Title
AR121843A2 (en) OPHTHALMIC FORMULATION AND METHOD TO IMPROVE PRESBYOPIA
TN2015000434A1 (en) Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
PH12015501703A1 (en) Trifluormethyl-substituted ring-fused pyrimidines and use thereof
CN103239707A (en) Eye drop for treating myopia
TN2014000298A1 (en) Substituted annulated pyrimidines and triazines, and use thereof
PE20150223A1 (en) ANTIBODIES ENHANCED ANTIBODIES AGAINST GROWTH AND DIFFERENTIATION FACTOR-8 AND THE USES OF THEM
AR096114A1 (en) ELIMINATION OF SODIUM SULPHATE FROM WASTEWATER TREATED BIOLOGICALLY
AR088866A1 (en) DEVICE AND METHOD FOR WATER TREATMENT
PH12016500608A1 (en) Cyclic thienouracil-carboxamides and use thereof
EP3778887A3 (en) Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of n-acetyl-aspartic acid
AR090804A1 (en) PROCEDURE FOR THE RECOVERY OF AROMA OF TE
CN203915789U (en) Neonatal jaundice blue-light treatment clothing
BR112014029308A2 (en) a method of improving liver function
CN104288813A (en) Air freshener
CN104758501A (en) Ointment for treating scald
CN103741335A (en) Aromatic anti-radiation fabric
CN102400392A (en) Natural silk fabric refining liquid
UA50454U (en) Method for treating and prophylaxis of bee varroosis
CN109984625A (en) A kind of pollution-free descalling technique
CN204814397U (en) Anion health care eye -shade
CN203282936U (en) Jade bottle
CN103798174A (en) Fish tank structure
CN102846530A (en) Novel herbal bath salt
CN104013645A (en) Prescription for treating deuteropathic deafness
CN103643508A (en) Elastic fiber fabric treating fluid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130814